logo
U.S. core capital goods orders unexpectedly fall; shipments rise moderately

U.S. core capital goods orders unexpectedly fall; shipments rise moderately

Globe and Mail25-07-2025
New orders for key U.S.-manufactured capital goods unexpectedly fell in June while shipments of those products increased moderately, suggesting that business spending on equipment slowed considerably in the second quarter.
Front-loading of activity ahead of President Donald Trump's aggressive and broad tariffs on imports resulted in business spending on equipment growing in the first quarter at the fastest pace since the third quarter of 2020.
While some of the tariff-related spending to avoid even higher goods prices has persisted, uncertainty over where tariff levels will eventually settle has prompted some businesses to hold off capital expenditures.
'This softness is consistent with the torrent of anecdotal reports in recent months that businesses are delaying their investment plans until they have more clarity on tariffs and the rest of the policy landscape,' said Stephen Stanley, chief U.S. economist at Santander U.S. Capital Markets.
Non-defense capital goods orders excluding aircraft, a closely watched proxy for business spending plans, dropped 0.7% last month after an upwardly revised 2.0% rebound in May, the Commerce Department's Census Bureau said on Friday.
Economists had forecast that these so-called core capital goods orders would rise 0.2% after a previously reported 1.7% jump in May. Shipments of core capital goods, which go into the calculation of the equipment spending component in the gross domestic product report, increased 0.4% after rising 0.5% in May. Those figures are not adjusted for inflation.
Economists said the data, when accounting for inflation, suggested that business spending on equipment sharply moderated last quarter after surging at a 23.7% annualized rate in the first quarter. Some even projected a mild contraction.
'Nominal core shipments have risen steadily since late last year, but almost all of this increase has reflected higher capital goods prices rather than stronger volumes,' said Oliver Allen, senior U.S. economist at Pantheon Macroeconomics.
'Underlying equipment investment probably will continue to grind lower, despite the tax advantages granted by the One Big Beautiful Bill, as uncertainty around trade policy will prompt many companies to keep capex projects on hold.'
The non-partisan Congressional Budget Office has estimated that the One Big Beautiful Bill's tax cuts and spending provisions would add $3.4 trillion to the nation's $36.2 trillion debt and only increase inflation-adjusted GDP by an average of 0.5% over 10 years. Trump signed the bill into law earlier this month. A survey from S&P Global on Thursday showed its flash manufacturing PMI contracted in July for the first time since December. S&P Global noted that 'any protectionist benefits of import tariffs were often outweighed by concerns over higher prices and rising costs.'
The Atlanta Fed is forecasting economic growth rebounded at a 2.4% annualized rate in the second quarter, largely reflecting a reversal in import flows, which contributed to GDP contracting at a 0.5% pace in the first quarter. The government is scheduled to publish its advance estimate of second-quarter GDP next week.
Nondefense capital goods orders plunged 24.0% in June after vaulting 50.0% in May. Shipments of these orders declined 0.9% after being unchanged in May.
Orders for durable goods, items ranging from toasters to aircraft meant to last three years or more, decreased 9.3% in June as commercial aircraft bookings came off their lofty levels. That partially reversed the 16.5% surge notched in May.
Commercial aircraft orders tumbled 51.8% last month after soaring 231.6% in the prior month. They were in part boosted by an order for 150 commercial planes placed with Boeing by Qatar Airways during Trump's visit to the Gulf Arab country in May.
Boeing reported on its website that it had received orders for 116 planes in June compared to 303 in May. The plane maker stands to benefit from trade deals being sought by the Trump administration.
'This may keep orders somewhat elevated, which should support production of planes,' said Veronica Clark, an economist at Citigroup. 'Deliveries of planes internationally would boost GDP through exports rather than business investment.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump's politically motivated sanctions against Brazil strain relations among old allies
Trump's politically motivated sanctions against Brazil strain relations among old allies

Toronto Star

time18 minutes ago

  • Toronto Star

Trump's politically motivated sanctions against Brazil strain relations among old allies

SAO PAULO (AP) — U.S. President Donald Trump has made clear who his new Latin America priority is: former Brazilian President Jair Bolsonaro, a personal and political ally. In doing so, he has damaged one of the Western hemisphere's most important and long-standing relationships, by levying 50% tariffs that begin to take effect Wednesday on the largest Latin America economy, sanctioning its main justice and bringing relations between the two countries to the lowest point in decades.

Fact Check: A look at White House claims about Canada's fentanyl fight ‘failure'
Fact Check: A look at White House claims about Canada's fentanyl fight ‘failure'

Winnipeg Free Press

time18 minutes ago

  • Winnipeg Free Press

Fact Check: A look at White House claims about Canada's fentanyl fight ‘failure'

The United States made good on its promise to slap hefty tariffs on Canada Friday as the countries failed to reach a trade deal by U.S. President Donald Trump's deadline. A fact sheet from the White House said Canada's 'failure' to address the opioid crisis was part of the reason for going ahead with the 35 per cent tariffs on certain goods from Canada. Here's a look at some of the claims made in the White House announcement, as well as the facts behind them: CANADA'S DRUG ENFORCEMENT 'FAILURE' 'Given Canada's continued failure to arrest traffickers, seize illicit drugs, or co-ordinate with U.S. law enforcement … further presidential action is necessary and appropriate to protect American lives and the national security and foreign policy of the United States,' the White House fact sheet states. THE FACTS In December, after the newly elected Trump began to press Canada about the flow of fentanyl into the United States, Canada pledged to invest $1.3 billion to bolster security at the border and strengthen the immigration system. A fentanyl czar, Kevin Brosseau, was appointed in February to co-ordinate the response. Since then, the federal government says it has invested heavily in fighting illicit drug production and trafficking, including another $200 million to target organized crime, enhanced border surveillance and staffing, 15 surveillance towers and other detection tools added to ports of entry. Canada has also deployed at the border new drones, four Black Hawk helicopters and a specialized plane for aerial surveillance, which collectively utilize infrared, heat-seeking and other advanced detection capabilities. The Canadian government says it's teaming up with the United States through a variety of joint efforts. 'Canada and the U.S. count on each other to share information, identify and protect against threats,' the Canada Border Services Agency told The Canadian Press in a statement. 'The CBSA and (U.S. Customs and Border Protection) each have officers embedded in our respective targeting centres and regularly share intelligence as well as several dedicated liaison officers working out of Canada's embassy in Washington, D.C.' The agency also pointed to its investigation in February and March, Operation Blizzard, which led to more than 2,600 seizures of suspected narcotics and precursors across the country transported through postal shipments, air cargo and shipping containers. The seizures included 1.73 kilograms of fentanyl, of which 1.44 kilograms were headed to the United States. Of the total drug seizures, the agency said, just 17.5 per cent was destined for the United States while 67.5 per cent had entered from south of the border. From Jan. 1 to April 30 this year, the agency said it seized 2.14 kilograms of fentanyl headed for the United States and 28 grams headed from the United States into Canada. Canadian law enforcement has shut down 47 fentanyl labs since 2018, data from Brosseau's office shows. SEIZURES AT NORTHERN BORDER The fact sheet says fentanyl seizures at the northern border this fiscal year 'have surpassed total seizures of the past three years combined.' THE FACTS U.S. Customs and Border Protection data shows 33.6 kilograms, of fentanyl has been seized at the northern border so far in fiscal year 2025, which ends Sept. 30. That is indeed more than the combined 26.8 kilograms seized in the 2022, 2023 and 2024 fiscal years, but it pales in comparison with the amount of fentanyl seized at the border with Mexico. The same data shows around 3,992 kilograms of fentanyl has been seized at the southwestern border of the United States so far this fiscal year. The amount of fentanyl seized coming into the United States through the northern border is 0.8 per cent of the total amount of fentanyl seized by border enforcement this fiscal year. DRUG POTENCY The White House claimed the amount of fentanyl seized at the Canadian border in the 2025 fiscal year 'could have killed more than 16 million Americans due to the drug's potency.' THE FACTS The United States Drug Enforcement Administration estimates that around two milligrams of fentanyl could be lethal. By that measure, the 33 kilograms seized at the Canadian border potentially could kill 16 million people. However, the actual number of opioid overdose deaths in the United States is measured in the thousands, not millions. Provisional data from the U.S. Centers for Disease Control and Prevention shows synthetic opioid deaths in the United States are trending downward, with 46,651 deaths recorded over the 12 months ending January 2025, compared with 72,718 in the previous 12-month period. This report by The Canadian Press was first published Aug. 5, 2025.

U.S. to initially impose ‘small tariff' on pharma imports, Trump says
U.S. to initially impose ‘small tariff' on pharma imports, Trump says

CTV News

time18 minutes ago

  • CTV News

U.S. to initially impose ‘small tariff' on pharma imports, Trump says

President Donald Trump talks to reporters on the South Lawn of the White House before he boards Marine One en route to Joint Base Andrews, Md., Friday, Aug. 1, 2025, in Washington. (AP Photo/Mark Schiefelbein) WASHINGTON — U.S. President Donald Trump said on Tuesday that the United States would initially place a 'small tariff' on pharmaceutical imports before hiking it to 150 per cent within 18 months and eventually to 250 per cent in an effort to boost domestic production. 'In one year, one and a half years maximum, it's going to go to 150 per cent and then it's going to go to 250 per cent because we want pharmaceuticals made in our country,' Trump told CNBC in an interview. He did not specify the initial tariff rate on pharmaceuticals. Trump said last month that pharmaceutical tariffs could reach as high as 200 per cent. He said in February that sectoral tariffs on pharmaceuticals and semiconductor chips would start at '25 per cent or higher,' rising substantially over the course of a year. Trump said on Tuesday that he plans to announce tariffs on semiconductors and chips in the 'next week or so,' but gave no further details. The United States has been conducting a national security review of the pharmaceutical sector, and the industry has been preparing for possible sector-specific tariffs. The administration has not announced when the results of that probe will be released. Several drugmakers have pledged multibillion-dollar investments in U.S. manufacturing as Trump threatens import tariffs, with AstraZeneca recently committing US$50 billion to expand its American operations. PhRMA, the main lobbying group for the industry, did not immediately respond to a request for comment. A framework agreement between the United States and the EU sets out that tariffs on pharmaceuticals and semiconductors are currently zero, but if the United States raises tariffs following its import investigation, they will be capped at 15 per cent. --- Reporting by Patrick Wingrove in New York, Andrea Shalal in Washington and Bhargav Acharya in Toronto; Editing by Doina Chiacu and Mark Porter

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store